Skip to main content
padlock icon - secure page this page is secure


Buy Article:

$42.00 + tax (Refund Policy)

We investigated to clarify the mechanism of action of AK-2123. V79 cells were used, and the effect of the substance was estimated with different end-points viz. induction of DNA breaks, micronuclei and clonogenic survival after hypoxic irradiation with different X-ray doses. After treatment with 0.1 mmol dm(-3) of the substance, sensitization by a factor of 1.8, 1.1 and 1.4 respectively, was calculated. By determining the enhancement ratio after treatment with the drug at 7-8 different concentrations varying between 0.001 and 50 mmol dm(-3), the concentration of the substance for half of the maximum sensitization (K-value) was estimated to be 40 mu mol dm(-3) (DNA breaks), 1200 mu mol dm(-3) (micronuclei) and 2000 mu mol dm(-3) (survival); the maximum sensitizer enhancement ratio was 2.4 (DNA breaks), 2.3 (micronuclei) and 2.4 (survival). No cytotoxic effects were found when the cells were treated with the drug in different concentrations for 30 minutes. However, after longer periods the compound was found to be cytotoxic both under aerobic and hypoxic conditions, in a concentration and time dependent manner. A post-irradiation enhancement of the sensitivity was noted when the drug was left in the medium for 24 hours after hypoxic as well as aerobic radiation exposure.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Document Type: Research Article


Publication date: April 1, 1995

More about this publication?
  • The International Journal of Oncology provides an international forum for the publication of the latest, cutting-edge research in the broad area of oncology and cancer treatment. The journal accepts original high quality works and reviews on all aspects of oncology research including carcinogenesis, metastasis, epidemiology, chemotherapy and viral oncology. Through fair and efficient peer review, the journal is dedicated to publishing top tier research in the field, offering authors rapid publication as well as high standards of copy-editing and production. The International Journal of Oncology is published on a monthly basis in both print and early online.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Information for Advertisers
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more